GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dicot AB (GREY:DCOIF) » Definitions » EV-to-EBIT

Dicot AB (Dicot AB) EV-to-EBIT : -0.86 (As of May. 22, 2024)


View and export this data going back to 2019. Start your Free Trial

What is Dicot AB EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Dicot AB's Enterprise Value is $3.89 Mil. Dicot AB's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was $-4.54 Mil. Therefore, Dicot AB's EV-to-EBIT for today is -0.86.

The historical rank and industry rank for Dicot AB's EV-to-EBIT or its related term are showing as below:

DCOIF' s EV-to-EBIT Range Over the Past 10 Years
Min: -5.87   Med: -1.05   Max: 0.55
Current: -3.72

During the past 7 years, the highest EV-to-EBIT of Dicot AB was 0.55. The lowest was -5.87. And the median was -1.05.

DCOIF's EV-to-EBIT is ranked worse than
100% of 676 companies
in the Drug Manufacturers industry
Industry Median: 17.145 vs DCOIF: -3.72

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Dicot AB's Enterprise Value for the quarter that ended in Mar. 2024 was $0.00 Mil. Dicot AB's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was $-4.54 Mil. Dicot AB's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was %.


Dicot AB EV-to-EBIT Historical Data

The historical data trend for Dicot AB's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dicot AB EV-to-EBIT Chart

Dicot AB Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBIT
Get a 7-Day Free Trial -2.51 -1.44 -1.51 -1.21 -4.82

Dicot AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.93 -1.84 -1.28 -4.82 -2.76

Competitive Comparison of Dicot AB's EV-to-EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, Dicot AB's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dicot AB's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Dicot AB's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Dicot AB's EV-to-EBIT falls into.



Dicot AB EV-to-EBIT Calculation

Dicot AB's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=3.890/-4.544
=-0.86

Dicot AB's current Enterprise Value is $3.89 Mil.
Dicot AB's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-4.54 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Dicot AB  (GREY:DCOIF) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Dicot AB's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Mar. 2024 ) =EBIT / Enterprise Value (Q: Mar. 2024 )
=-4.544/0
= %

Dicot AB's Enterprise Value for the quarter that ended in Mar. 2024 was $0.00 Mil.
Dicot AB's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-4.54 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Dicot AB EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Dicot AB's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Dicot AB (Dicot AB) Business Description

Traded in Other Exchanges
Address
Dag Hammarskjolds vag 30, Uppsala, SWE, SE 752 37
Dicot AB is engaged in developing drugs against sexual dysfunction in Sweden. Its important products are Libiguin which is used for the treatment of erectile dysfunction and premature ejaculation in men, as well as potentially also for the treatment of decreased lust.

Dicot AB (Dicot AB) Headlines

No Headlines